Recent developments with Corcept Therapeutics Inc (CORT) have led to the company’s beta value being reach 0.54 cents.
A new trading day began on Monday, with Corcept Therapeutics Inc (NASDAQ: CORT) stock price down -3.09% from the previous day of trading, before settling